Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-13

Clinical Trial Update: Efficacy and Safety of Topical Hydrocortisone on Signs and Symptoms of Dry Eye Associated to Meibomian Gland Dysfunction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of topical hydrocortisone for signs and symptoms of dry eye associated with Meibomian gland dysfunctio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • topical hydrocortisone (hydrocortisone)

Snippet

Sponsor: Laboratorios Thea, Spain | Conditions: Dry Eye, Meibomian Gland Dysfunction | Phase 4 | Status: UNKNOWN